PGY-2 Oncology Residency Pharmacy

The Medical University of South Carolina (MUSC) Health is a tertiary care teaching hospital that serves the colleges of medicine, dentistry, nursing, allied health, and pharmacy. Included in the patient population served by MUSC are hematology/oncology patients from the greater Charleston area, the surrounding low country of South Carolina, and out of state referrals. MUSC serves these patients through a dedicated inpatient floor in the Ashley River Tower Hospital, the MUSC Children’s Hospital, and through several outpatient oncology clinics and infusion areas including the NCI-designated Hollings Cancer Center, North Charleston, and East Cooper clinics. For this residency program, the resident will participate in care of this broad patient population focusing on inpatient and ambulatory management.

PGY-2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY-2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Specific residency goals and objectives will be established in the beginning of the residency year and modified according to the resident’s interests, previous experiences, and advisor input. To meet the purpose of the residency, the resident will advance to achieve the following outcomes:

  • Serve as an authoritative resource on the optimal use of medications used to treat individuals with cancer.
  • Optimize the outcomes of the care of individuals with cancer by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.
  • Manage and improve the medication-use process in oncology patient care areas.
  • Demonstrate excellence in the provision of training or educational activities for health care professionals and health care professionals in training.
  • Sustain the ongoing development of expertise and professionalism in the practice of oncology pharmacy.
  • Conduct oncology pharmacy practice research and create documents worthy of presentation or publication on cancer-related topics.
  • Function effectively in oncology settings participating in clinical investigations.

The PGY-2 Oncology Pharmacy Residency at MUSC is a one-year post-graduate training program designed to develop essential knowledge and skills for contemporary health-system pharmacy practice at a major academic medical center or community-based hospital, or position in academia. The residency program provides the flexibility to adapt to the resident’s specific learning needs and goals. The training is provided through concentrated clinical rotational and longitudinal experiences.

There are 10 required learning experiences, ranging in 2 weeks duration to longitudinal:

Orientation/Investigational Drug Services | 1 month
Inpatient Malignant Hematology | 1 month
Outpatient Malignant Hematology | 1 month
Outpatient BMT | 1 month
Solid Tumors | 4 months
Research/Academia | 1 month
Palliative Care | 3 weeks
Clinical Operations On-call | Longitudinal
Oncology Practice Management | Longitudinal
Oncology Staffing | Longitudinal

The program is flexible in its design to offer the following elective rotations:

Antimicrobial Stewardship | 1 month
Critical Care | 1 month
Drug Information | 1 month
Inpatient BMT | 2 weeks
Inpatient Oncology | 2 weeks
Investigational Drug Services | 1 month
Pediatric Oncology | 1 month
Academician Preparation Program (APP)** | Longitudinal
Pharmacy Research Certificate | Longitudinal

*The resident may repeat or customize any prior experience to achieve their residency goals and needs.
**The APP is available to residents who have not completed a similar program during their PGY-1 residency.

Carolyn Smith Bondarenka, PharmD, MBA, BCPS
Manager, Oncology Pharmacy Services
Adjunct Assistant Professor

Kasey Jackson, PharmD, BCOP
Clinical Pharmacy Specialist

James Davis, PharmD, BCPS
Clinical Pharmacist

Jennifer MacDonald, PharmD, BCOP
Clinical Pharmacy Specialist

Kathy Hogan Edwards, PharmD, BCPS, BCOP
Clinical Pharmacy Specialist
Adjunct Assistant Professor

Jagoda Misniakiewicz, PharmD
Clinical Pharmacy Specialist

Anastasia Finn Graham, PharmD, BCOP
Clinical Pharmacy Specialist
Adjunct Assistant Professor

Amy Sion, PharmD
Clinical Pharmacy Specialist
Adjunct Assistant Professor

Andy Perez Maldonado, PharmD, BCOP
Clinical Pharmacy Specialist
Residency Program Director – Oncology
Adjunct Assistant Professor

*Additional preceptors that the resident will work with during staffing, orientation, clinical on-call and during elective rotations not listed.

Each clinical preceptor will be responsible for the coordination of his/her own learning experience and any necessary modifications, with the assistance of the RPD, to achieve the resident’s goals. The residency preceptor will exhibit the characteristics and aptitude necessary for residency training including the mastery of the four preceptor roles fulfilled when teaching clinical problem solving (direct instruction, modeling, coaching and facilitation). The residency preceptor will guide and monitor the resident’s activity and service throughout the learning experience. The residency preceptor will provide ongoing formative and summative evaluations of the resident’s performance, with the goal of advancing the resident’s competency on the specific goals assigned to the experience.

The specific responsibilities are to:

  • Understand the resident’s responsibilities to the learning experience and to facilitate ongoing activities such as projects, in-services, student discussions, and manuscript preparation.
  • Develop and maintain goals and objectives for the specific learning experience(s).
  • Review the resident’s customized training plan and resident’s previous performance and modify the learning experience accordingly.
  • Orient the resident to the rotation’s setting and monitor/evaluate/critique the resident’s performance during the experience.
  • Provide the resident a midpoint in written and verbal format, and be able to complete the final summative PharmAcademic evaluation by month’s end as outlined in the residency manual.
  • Advise the RPD of any appropriate interventions that may be needed relevant to the resident’s performance.
  • Actively participate in regular feedback sessions in which preceptors and the RPD consider overall program changes based on evaluations, observations, and direct resident feedback and surveys.

Each resident is assigned an advisor at the beginning of the PGY2 year. Advisors are appointed by the RPD. The residency advisor will be responsible for the supervision, guidance, and on-going evaluation of the resident’s progress throughout the residency, as well as serve in an informal professional mentoring role.

Specific responsibilities include:

  • Contacting resident prior to the start of the PGY2 year to offer guidance on rotation selection/scheduling questions and to ensure the resident is working on licensure (if out of state) and a place to live
  • Meet with the resident during the orientation month to help the resident in the design of his/her customized plan, selecting a residency research project, modifying rotation schedule as necessary, etc.
  • Review all evaluations and participate in the resident’s quarterly evaluation.
  • Assist RPD with customizing the resident’s training plan as necessary based on the resident’s progress.
  • Insure resident is setting and meeting all project deadlines.
  • Serve as a mentor to the resident by assisting with career exploration and applying and interviewing for jobs.

The residents’ role is that of a student, novice practitioner, and emerging clinician and/or administrator and educator. The resident is to participate in ongoing clinical and administrative services with the assistance of the residency preceptor and develop their skill set into a competent clinical practitioner and/or future administrator. The resident must accept and apply constructive criticism in addition to performing self-evaluations on their performance.

In order to promote an effective and productive residency experience, the relationship between a resident and rotation preceptor must be highly communicative, and a meaningful dialogue must be achieved. Specifically, the resident will:

  • Sign off on the learning experience orientation form on the first day of each new clinical rotation.
  • Maintain strict deadlines for PharmAcademic evaluation and assessment requirements as outlined in the MUSC residency manual. This involves project work, MUE work, seminar preparation, and any other educational or in-service/presentation that will require preceptor feedback.
  • Understand the preceptor’s expectations for daily activities, services provided and preceptor contact.
  • Participate in pharmacy functions (e.g. rounds, patient care conferences, lectures, departmental meetings, clinical staff meetings, journal clubs, seminars, and RITEs) in accordance to the MUSC residency manual.
  • As outlined by the clinical preceptor, provide a detailed account of activities as they relate to the goals and objectives of the learning experience.
  • Maintain active communication with the preceptor, advisor and/or RPD concerning any planned off-service activities (eg. meetings, seminars, projects, staffing, on-call commitments) that the resident will be participating in during the rotation.

Each residency experience is thoughtfully designed to provide the resident with the tools needed to successfully complete and achieve all* of the required competency areas, goals and objectives for PGY2 Pharmacy Residencies in Oncology. This will include the following under the “achieved category”:

  • Competency Area R1: Patient Care
  • Competency Area R2: Advancing Practice and Improving Patient Care
  • Competency Area R3: Leadership and Management
  • Competency Area R4: Teaching, Education, and Dissemination of Knowledge
  • Competency Area R5: Oncology Investigational Drugs

A. *The resident is expected to demonstrate proficiency in 95% or above of all activities linked to these specific outcomes via the various goals and objectives assigned from the learning experiences to successfully complete the MUSC program. The resident will first observe, learn, act, and then master a particular activity, which will deem them having achieved that goal. This again will be highly individualized and not applied to every resident in exactly the same manner.

B. For the various elective competency areas, goals and objectives for PGY2 Pharmacy Residencies in Oncology, the resident may or may not have elective goals and objectives assigned based upon their individual customized residency plan. If a competency area is assigned, it must be satisfactorily completed (at least 95% proficient) to achieve a residency certificate from the MUSC program. The following are elective outcomes which may be selected:

  • Competency Area E1: Teaching and Learning
  • Competency Area E2: Initiating an Oncology Pharmacy-Related Service
  • Competency Area E3: Oncology Credentialing
  • Competency Area E4: Publishing
  • Competency Area E5: Management of Oncology Medical Emergencies
  • Competency Area E6: Specialty Pharmacy.
  • All PGY2 residents have their PGY1 residency certificate on file.
  • Attain an “achieved” on 95% of the RLS objectives as assessed by the RPD on the last quarterly evaluation (June).
  • No NI’s may be present upon graduation of the program.
  • Complete all assigned evaluations
  • Complete end-of-year self-assessment
  • Participate in a medication use evaluation(s). Provide a written document with methods, findings, and recommendations.
  • Complete a service or research project designed to improve the services of the Pharmacy ICCE.
  • Present the project at an approved local, national, regional or state meeting.
  • Prepare a manuscript suitable for publication in a peer-reviewed biomedical journal. Editorial assistance by the preceptor is required.
  • Complete the ASHP oncology residency disease-specific appendix
  • Prepare and present an ACPE-approved continuing education seminar.
  • Prepare and present a lecture for pharmacy students.
  • Prepare a drug monograph OR update/create a guideline/protocol
  • Evaluate 4 Grand Rounds presentations throughout the year

The PGY2 Oncology Residency is seeking candidates who have broad rotational and work experience, have experience giving presentations, conducting and presenting research, are active in professional organizations, have demonstrated effective communication skills, have a track record of successfully balancing responsibilities and completing assignments, and have a strong scholarly foundation to build upon. Residency candidates are selected for interviews in accordance with the program’s candidate selection procedures and evaluated for ranking after interview by the scoring rubric.